Uplinza

AstraZeneca spinoff scores maiden FDA approval, where it will field Alexion competition and an imminent Roche rival
Endpoints
Fri, 06/12/20 - 10:40 am
Viela Bio
AstraZeneca
Uplinza
FDA
NMOSD